Zevra Therapeutics (ZVRA) Change in Cash (2014 - 2026)
Zevra Therapeutics (ZVRA) reported Change in Cash of $49.73 million for Q2 2026, up 379.4% from $10.37 million a year earlier and up 49.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Change in Cash (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Zevra Therapeutics' Change in Cash came in at $97.61 million; for FY2025, it was $28.62 million.
- Change in Cash has a five-year compound annual growth rate of 106.2% (FY2020 to FY2025).
- By year, Change in Cash came in at -$9.26 million in FY2024, -$22.42 million in FY2023, -$46.88 million in FY2022 and $108.02 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Change in Cash since Q2 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at $33.19 million (Q1 2026), $7.97 million (Q4 2025) and $6.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.67 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.27 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.49 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 739.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.64 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -4.45 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -727.00 Mn |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn | 49.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.73 Mn |
| Mar 31, 2026 | 33.19 Mn |
| Dec 31, 2025 | 7.97 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 10.37 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Dec 31, 2024 | -20.25 Mn |
| Sep 30, 2024 | 14.78 Mn |
| Jun 30, 2024 | -3.59 Mn |
| Mar 31, 2024 | -200,000.00 |
| Dec 31, 2023 | -220,000.00 |
| Sep 30, 2023 | -22.93 Mn |
| Jun 30, 2023 | 26.02 Mn |
| Mar 31, 2023 | -25.29 Mn |
| Dec 31, 2022 | -4.59 Mn |
| Sep 30, 2022 | -6.72 Mn |
| Jun 30, 2022 | -23.43 Mn |
| Mar 31, 2022 | -12.13 Mn |
| Dec 31, 2021 | -19.16 Mn |
| Sep 30, 2021 | -792,000.00 |
API Access
Zevra Therapeutics Change in Cash API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-cash&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-cash", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-cash&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();